Skip to content

Research and application of cerebrovascular disease organization management and decision system

Improvement of medical quality and outcomes through intelligent management and decision system of cerebrovascular diseases based on hospital information system (Research and application of cerebrovascular disease organization management and decision system)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101596
Enrollment
Unknown
Registered
2025-04-27
Start date
2024-12-02
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Control group:Conventional diagnosis and treatment.
Intervention group:Organizational management based clinical decision support system for acute ischemic stroke complications.

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosed with ischemic stroke confirmed by MRI or brain CT. 2.Within 7 days from onset of symptoms. 3.With a prestroke mRS score of 0-1. 4.With a NIHSS score of >=2 at admission (limb score >=1). 5.Admission from the emergency department or outpatient service. 6.Voluntary informed consent.

Exclusion criteria

Exclusion criteria: 1.Diagnosis of other cerebrovascular diseases (cerebral hemorrhage, subarachnoid hemorrhage, cerebral venous sinus thrombosis, etc.); 2.Diagnosis of non-cerebrovascular disease (central nervous system infection, epilepsy, metabolic encephalopathy, etc.). 3.Ischemic stroke with negative DWI. 4.Being tested for interventions such as drugs or instruments. 5.Pregnancy or 6 weeks postpartum. 6.With a life expectancy of less than 3 months or who were unable to complete the study follow-up for other reasons.

Design outcomes

Primary

MeasureTime frame
Incidence of unfavorable functional outcomes (mRS Score 2-5).;The incidence of severe or moderate bleeding events;

Secondary

MeasureTime frame
Incidence of hospital complications;Incidence of recurrent ischemic stroke;Incidence of unfavorable functional outcomes (mRS Score 2-5).;Incidence of compound vascular events;All-cause mortality;Average length of stay;Average total hospital expenses;Mortality rate;Adverse event;Serious adverse event;The incidence of severe or moderate bleeding events;Incidence of all bleeding events;Comprehensive evalution index;

Countries

China

Contacts

Public ContactZixiao Li

Beijing Tiantan Hospital, Capital Medical University

lizixiao2008@hotmail.com+86 10 59978555

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026